Human thrombin + Bovine thrombin
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hemostasis
Conditions
Hemostasis
Trial Timeline
Dec 1, 2013 → Nov 1, 2015
NCT ID
NCT02014402About Human thrombin + Bovine thrombin
Human thrombin + Bovine thrombin is a phase 2 stage product being developed by Grifols for Hemostasis. The current trial status is completed. This product is registered under clinical trial identifier NCT02014402. Target conditions include Hemostasis.
What happened to similar drugs?
1 of 3 similar drugs in Hemostasis were approved
Approved (1) Terminated (1) Active (2)
Hype Score Breakdown
Clinical
12
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02014402 | Phase 2 | Completed |
Competing Products
4 competing products in Hemostasis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Epoetin alfa + Standard of Care | Johnson & Johnson | Approved | 35 |
| FS VH S/D 500 s-apr, 60-seconds polymerization time + FS VH S/D 500 s-apr, 120-seconds polymerization time | Baxter | Phase 2 | 32 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Baxter | Phase 3 | 37 |
| TISSEEL Lyo | Baxter | Phase 3 | 37 |